<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-3773</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ШКОЛА НЕФРОЛОГА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EDUCATIONAL MATERIALS</subject></subj-group></article-categories><title-group><article-title>Ятрогенная гиперкалиемия: диагностика и лечение</article-title><trans-title-group xml:lang="en"><trans-title>Iatrogenic hyperkalaemia - points to consider in diagnosis and management</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костас</surname><given-names>С. Сиамопулос</given-names></name><name name-style="western" xml:lang="en"><surname>Kostas</surname><given-names>C. Siamopoulos</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мозес</surname><given-names>Элисаф</given-names></name><name name-style="western" xml:lang="en"><surname>Moses</surname><given-names>Elisaf</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костас</surname><given-names>Катоподис</given-names></name><name name-style="western" xml:lang="en"><surname>Kostas</surname><given-names>Katopodis</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Отдел внутренней медицины. Отделение нефрологии, Университетский госпиталь, Иоаннина, Греция</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2000</year></pub-date><pub-date pub-type="epub"><day>28</day><month>06</month><year>2025</year></pub-date><volume>2</volume><issue>3</issue><fpage>176</fpage><lpage>181</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Костас С.С., Мозес Э., Костас К., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Костас С.С., Мозес Э., Костас К.</copyright-holder><copyright-holder xml:lang="en">Kostas C.S., Moses E., Kostas K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/3773">https://journal.nephro.ru/jour/article/view/3773</self-uri><abstract><p>Гиперкалиемия является угрожающим жизни электролитным нарушением. В обычных условиях она наблюдается редко, благодаря гомеостатическим механизмам, обеспечивающим поддержание нормального уровня калия в плазме крови. Среди этих механизмов особое место занимает способность почек усиленно экскретировать калий при повышении его уровня в крови. Следовательно, гиперкалиемия почти всегда связана с повреждением этого механизма. Однако при острой и хронической почечной недостаточности ее развитию может способствовать и избыточное поступление калия извне. ** Публикуется по согласованию с автором и с разрешения Oxford University Press. ** Перевод И.Г. Ким</p></abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Brown R.S. Extrarenal potassium homeostasis. Kidney Int 1986; 30: 116-127.</mixed-citation><mixed-citation xml:lang="en">Brown R.S. Extrarenal potassium homeostasis. Kidney Int 1986; 30: 116-127.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Stanton B.A. Renal potassium transport: Morphological and functional adaptations. Am J Physiol 1989; 257: R989-R997.</mixed-citation><mixed-citation xml:lang="en">Stanton B.A. Renal potassium transport: Morphological and functional adaptations. Am J Physiol 1989; 257: R989-R997.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wright F.S. Renal potassium handling. Semin Nephrol 1987; 7: 174-184.</mixed-citation><mixed-citation xml:lang="en">Wright F.S. Renal potassium handling. Semin Nephrol 1987; 7: 174-184.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rabelink T.J., Koomans Н.А., Hene’ R.J., Dorhout Mees E.J. Early and late adjustment to potassium loading in humans. Kidney Int 1990; 38: 942-947.</mixed-citation><mixed-citation xml:lang="en">Rabelink T.J., Koomans Н.А., Hene’ R.J., Dorhout Mees E.J. Early and late adjustment to potassium loading in humans. Kidney Int 1990; 38: 942-947.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rose B.D. Hyperkalemia In: Rose B.D., ed. Clinical Physiology of Acid-Base and Electrolyte Disorders, 4th edn. McGraw Hill, New York, 1994; 823-862.</mixed-citation><mixed-citation xml:lang="en">Rose B.D. Hyperkalemia In: Rose B.D., ed. Clinical Physiology of Acid-Base and Electrolyte Disorders, 4th edn. McGraw Hill, New York, 1994; 823-862.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ponce S.P., Jennings A.E., Madias N.E., Harrington J.T. Drug-induced hyperkalemia. Medicine 1985; 64: 357-370.</mixed-citation><mixed-citation xml:lang="en">Ponce S.P., Jennings A.E., Madias N.E., Harrington J.T. Drug-induced hyperkalemia. Medicine 1985; 64: 357-370.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">DeVita M.V., Han H., Chan R., Zabetakis P.M., Gleim G.W., Michelis M.F. Drug use and the elderly in relation to changing etiologies of hyperkalemia. Geriatr Nephrol Urol 1991; 1: 41-45.</mixed-citation><mixed-citation xml:lang="en">DeVita M.V., Han H., Chan R., Zabetakis P.M., Gleim G.W., Michelis M.F. Drug use and the elderly in relation to changing etiologies of hyperkalemia. Geriatr Nephrol Urol 1991; 1: 41-45.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rimmer J.M., Horm J.F., Gennari F.J. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987; 147: 867-869.</mixed-citation><mixed-citation xml:lang="en">Rimmer J.M., Horm J.F., Gennari F.J. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987; 147: 867-869.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Michelis M.F. Hyperkalemia in the elderly. Am J Kidney Dis 1990; 16; 296-299.</mixed-citation><mixed-citation xml:lang="en">Michelis M.F. Hyperkalemia in the elderly. Am J Kidney Dis 1990; 16; 296-299.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hegstad R., Brown R.D., Jiang N.-S. et al. Aging and aldosterone. Am J Med 1983; 74: 442-448.</mixed-citation><mixed-citation xml:lang="en">Hegstad R., Brown R.D., Jiang N.-S. et al. Aging and aldosterone. Am J Med 1983; 74: 442-448.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mulkerrin E., Epstein F.H., Clark B.A. Aldosterone responses to hyperkalemia in healthy elderly humans. J Am Soc Nephrol 1995; 6: 1459-1462.</mixed-citation><mixed-citation xml:lang="en">Mulkerrin E., Epstein F.H., Clark B.A. Aldosterone responses to hyperkalemia in healthy elderly humans. J Am Soc Nephrol 1995; 6: 1459-1462.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">DuBose T.D. Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights. Kidney Int 1997; 51: 591-602.</mixed-citation><mixed-citation xml:lang="en">DuBose T.D. Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights. Kidney Int 1997; 51: 591-602.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Alappan R., Perazella M.A., Buller G.K. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med 1996; 124: 316-320.</mixed-citation><mixed-citation xml:lang="en">Alappan R., Perazella M.A., Buller G.K. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med 1996; 124: 316-320.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Elisaf M., Terrovitou Ch., Tomos P., Siamopoulos К.С. Severe hyperkalaemia after co-trimoxazole administration in a patient with hyporeninaemic hypoaldosteronism. Nephrol Dial Transplant 1997; 12: 1254-1255.</mixed-citation><mixed-citation xml:lang="en">Elisaf M., Terrovitou Ch., Tomos P., Siamopoulos К.С. Severe hyperkalaemia after co-trimoxazole administration in a patient with hyporeninaemic hypoaldosteronism. Nephrol Dial Transplant 1997; 12: 1254-1255.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">DcFronzo R.A. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 1980; 17: 118-114.</mixed-citation><mixed-citation xml:lang="en">DcFronzo R.A. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 1980; 17: 118-114.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Williams G.H. Hyporeninemic hypoaldosleronism. N Engl J Med 1986; 314; 1041-1042.</mixed-citation><mixed-citation xml:lang="en">Williams G.H. Hyporeninemic hypoaldosleronism. N Engl J Med 1986; 314; 1041-1042.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Choi M.J, Fernandez P.C, Patnaik A. et al. Trimethoprim-induced hyperkalemia in a patient with AIDS. N EngI J Med 1993; 328: 703-706.</mixed-citation><mixed-citation xml:lang="en">Choi M.J, Fernandez P.C, Patnaik A. et al. Trimethoprim-induced hyperkalemia in a patient with AIDS. N EngI J Med 1993; 328: 703-706.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Velazquez H., Perazella M.A., Wright F.S., Ellison D.H. Renal mechanism of trimethoprim-incluced hyperkalemia. Ann Intern Med 1993; 119: 296-301.</mixed-citation><mixed-citation xml:lang="en">Velazquez H., Perazella M.A., Wright F.S., Ellison D.H. Renal mechanism of trimethoprim-incluced hyperkalemia. Ann Intern Med 1993; 119: 296-301.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Schreiber M., Schlanger L.E., Chcn C.-B. et al. Antikaliuretic action of trimethoprim is minimized by raising urine pH. Kidney Int 1996; 49: 82-87.</mixed-citation><mixed-citation xml:lang="en">Schreiber M., Schlanger L.E., Chcn C.-B. et al. Antikaliuretic action of trimethoprim is minimized by raising urine pH. Kidney Int 1996; 49: 82-87.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Schreiber M., Halperin M.L. Urea excretion rate as a contributor to trimethoprim-induced hyperkalemia. Aim Intern Med 1994; 120: 166-167.</mixed-citation><mixed-citation xml:lang="en">Schreiber M., Halperin M.L. Urea excretion rate as a contributor to trimethoprim-induced hyperkalemia. Aim Intern Med 1994; 120: 166-167.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Reiser I.W., Chou S.-Y., Brown M.I., Porush J.G. Reversal of trimethoprim-induced antikaliuresis. Kidney Int 1996; 50: 2063-2069.</mixed-citation><mixed-citation xml:lang="en">Reiser I.W., Chou S.-Y., Brown M.I., Porush J.G. Reversal of trimethoprim-induced antikaliuresis. Kidney Int 1996; 50: 2063-2069.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zager R.A. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Jnt 1996; 49: 314-326.</mixed-citation><mixed-citation xml:lang="en">Zager R.A. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Jnt 1996; 49: 314-326.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Prendergast B.D., George C.F. Drug-induced rhabdomyolysis mechanisms and management. Postgrad Med J 1993; 69: 333-336.</mixed-citation><mixed-citation xml:lang="en">Prendergast B.D., George C.F. Drug-induced rhabdomyolysis mechanisms and management. Postgrad Med J 1993; 69: 333-336.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Terrovitou C.T., Milionis H.J., Elisaf M.S. Acute rhabdomyolysis after bezafibrate re-exposure. Nephron (in press).</mixed-citation><mixed-citation xml:lang="en">Terrovitou C.T., Milionis H.J., Elisaf M.S. Acute rhabdomyolysis after bezafibrate re-exposure. Nephron (in press).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Demedts W., Desager Z., Belpaire F., Rinqon S., Lameire N. Life threatening hyperkalemia associated with clofibrale-induced myopathy in a CAPD patient. Perit Dial Bull 1983: 3: 15-16.</mixed-citation><mixed-citation xml:lang="en">Demedts W., Desager Z., Belpaire F., Rinqon S., Lameire N. Life threatening hyperkalemia associated with clofibrale-induced myopathy in a CAPD patient. Perit Dial Bull 1983: 3: 15-16.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Textror S.C., Bravo E.L., Fouad F.M., Tarazi R.C. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril Am J Med 1982; 73:719-725.</mixed-citation><mixed-citation xml:lang="en">Textror S.C., Bravo E.L., Fouad F.M., Tarazi R.C. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril Am J Med 1982; 73:719-725.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Doman К., Pcrlmuttcr J.A., Muhamincdi M. et al. Life-threatening hyperkalemia associated with captopril administration. South Med J 1993; 86: 1269-1272.</mixed-citation><mixed-citation xml:lang="en">Doman К., Pcrlmuttcr J.A., Muhamincdi M. et al. Life-threatening hyperkalemia associated with captopril administration. South Med J 1993; 86: 1269-1272.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gorriz J.L., Garcia-Ramos J.L., Pallardo L.M. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment. Nephrol Dial Transplant 1995; 10: 2371-2372.</mixed-citation><mixed-citation xml:lang="en">Gorriz J.L., Garcia-Ramos J.L., Pallardo L.M. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment. Nephrol Dial Transplant 1995; 10: 2371-2372.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Chan MK. Sustained-release bezafibrate соrrects lipid abnormalities in patients on continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 56-61.</mixed-citation><mixed-citation xml:lang="en">Chan MK. Sustained-release bezafibrate соrrects lipid abnormalities in patients on continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 56-61.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Van Puijenbroek E.P., DuBuf-Vcreijken P.W.G., Spooren P.F.M.J., Van Doormaal J.J. Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. J Intern Med 1996; 240: 403-404.</mixed-citation><mixed-citation xml:lang="en">Van Puijenbroek E.P., DuBuf-Vcreijken P.W.G., Spooren P.F.M.J., Van Doormaal J.J. Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. J Intern Med 1996; 240: 403-404.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Panuccio V., Enia G., Parlongo S., Cutrupi S., Zoccali C. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient. Nephron 1996; 73: 736.</mixed-citation><mixed-citation xml:lang="en">Panuccio V., Enia G., Parlongo S., Cutrupi S., Zoccali C. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient. Nephron 1996; 73: 736.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bcdani P.L., Perini L., Gilli P. Acute rhahdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis. Nephron 1994: 68: 512-513.</mixed-citation><mixed-citation xml:lang="en">Bcdani P.L., Perini L., Gilli P. Acute rhahdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis. Nephron 1994: 68: 512-513.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta P., Franco-Saenz R., Mulrow P.J. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin and potassium stimulated aldosterone secretion. Hypertension 1995; 25: 443-448.</mixed-citation><mixed-citation xml:lang="en">Gupta P., Franco-Saenz R., Mulrow P.J. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin and potassium stimulated aldosterone secretion. Hypertension 1995; 25: 443-448.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Pratt J. Role of angiotensin II in potassium mediated aldosterone secretion in the dog. J Clin Invest 1982: 70: 667-672.</mixed-citation><mixed-citation xml:lang="en">Pratt J. Role of angiotensin II in potassium mediated aldosterone secretion in the dog. J Clin Invest 1982: 70: 667-672.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Veterans Administration Cooperative Study Group on Antihypertensive Agents. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Arch Intern Med 1984: 144: 1947-1953.</mixed-citation><mixed-citation xml:lang="en">Veterans Administration Cooperative Study Group on Antihypertensive Agents. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Arch Intern Med 1984: 144: 1947-1953.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Grossman A., Eckland D., Price P. et al. Captoprii: reversible renal failure with severe hyperkalemia. Lancet 1980: 1: 712.</mixed-citation><mixed-citation xml:lang="en">Grossman A., Eckland D., Price P. et al. Captoprii: reversible renal failure with severe hyperkalemia. Lancet 1980: 1: 712.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Packer M., Lee W.H. Provocation of’ hyper- and hypokalemic sudden death during treatment with and withdrawal of converting enzyme inhibition in severe chronic congestive heart failure. Am J Cardiol 1986; 57: 347-370.</mixed-citation><mixed-citation xml:lang="en">Packer M., Lee W.H. Provocation of’ hyper- and hypokalemic sudden death during treatment with and withdrawal of converting enzyme inhibition in severe chronic congestive heart failure. Am J Cardiol 1986; 57: 347-370.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Burnakis T.G., Mioduch H.J. Combined therapy with captopril and potassium supplementation. Arch lntern Med 1984: 144: 2371-2372.</mixed-citation><mixed-citation xml:lang="en">Burnakis T.G., Mioduch H.J. Combined therapy with captopril and potassium supplementation. Arch lntern Med 1984: 144: 2371-2372.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sterns R.H., Spital A. Disorders of internal potassium balance. Semin Nephrol 1987; 7: 206-222.</mixed-citation><mixed-citation xml:lang="en">Sterns R.H., Spital A. Disorders of internal potassium balance. Semin Nephrol 1987; 7: 206-222.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">BauerJ.H. Effects of propranolol therapy on renal function and body fluid composition. Arch Intern Med 1983; 14: 927-931.</mixed-citation><mixed-citation xml:lang="en">BauerJ.H. Effects of propranolol therapy on renal function and body fluid composition. Arch Intern Med 1983; 14: 927-931.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Lim M., Lipton R.A.F., Wolff C.B., Band D.M. Propranolol, exercise, and arterial plasma potassium. Lancet 1981; 12: 591.</mixed-citation><mixed-citation xml:lang="en">Lim M., Lipton R.A.F., Wolff C.B., Band D.M. Propranolol, exercise, and arterial plasma potassium. Lancet 1981; 12: 591.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Belhune D., McKay R. Paradoxical changes in serum-potassium during cardiopulmonary bypass in association with non-cardioselective beta blockade. Lancet 1978; 12: 380-381.</mixed-citation><mixed-citation xml:lang="en">Belhune D., McKay R. Paradoxical changes in serum-potassium during cardiopulmonary bypass in association with non-cardioselective beta blockade. Lancet 1978; 12: 380-381.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lowenthal D.T., Affrime M.B., Rosenthal L., Gould A.B., Borruso J., Falkner B. Dynamic and biochemical responses to single and repeated doses clonidine during dynamic physical activity. Clin Pharmacol Ther 1982; 32: 18-24.</mixed-citation><mixed-citation xml:lang="en">Lowenthal D.T., Affrime M.B., Rosenthal L., Gould A.B., Borruso J., Falkner B. Dynamic and biochemical responses to single and repeated doses clonidine during dynamic physical activity. Clin Pharmacol Ther 1982; 32: 18-24.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenihal L.S., Lowenthal D.T., Affrime M.B., Falkner B., Gould A.B. The renin-aldosterone-potassium response to methyldopa during dynamic physical activity. Clin Phurniacul Ther 1982; 31: 264-265.</mixed-citation><mixed-citation xml:lang="en">Rosenihal L.S., Lowenthal D.T., Affrime M.B., Falkner B., Gould A.B. The renin-aldosterone-potassium response to methyldopa during dynamic physical activity. Clin Phurniacul Ther 1982; 31: 264-265.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Castellino P., Bia M.J., DeFronzo R.A. Adrenergic modulation of potassium metabolism in uremia. Kidney Int 1990; 37: 773-798.</mixed-citation><mixed-citation xml:lang="en">Castellino P., Bia M.J., DeFronzo R.A. Adrenergic modulation of potassium metabolism in uremia. Kidney Int 1990; 37: 773-798.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tan S.Y., Shapiro R., Franco R. et al. Indomethacin induced prostaglandin inhibition with hyperkalemia; A reversible cause of hyporeninic hypoaldosteronism. Ann Intern Med 1979; 90: 783-785.</mixed-citation><mixed-citation xml:lang="en">Tan S.Y., Shapiro R., Franco R. et al. Indomethacin induced prostaglandin inhibition with hyperkalemia; A reversible cause of hyporeninic hypoaldosteronism. Ann Intern Med 1979; 90: 783-785.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Garella S., Matarese R.A. Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine 1984; 3:165-181.</mixed-citation><mixed-citation xml:lang="en">Garella S., Matarese R.A. Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine 1984; 3:165-181.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Zimran A., Kramer M., Plaskin M., Hershko C. Incidence of hyperkalaemia induced by indomethacin in a hospital population. Lancet 1985; 291: 107-108.</mixed-citation><mixed-citation xml:lang="en">Zimran A., Kramer M., Plaskin M., Hershko C. Incidence of hyperkalaemia induced by indomethacin in a hospital population. Lancet 1985; 291: 107-108.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Phelps K.R., Oh M.S., Carroll H.J. Heparin-induced hyperkalemia. Report of a case Nephron 1980; 25: 254.</mixed-citation><mixed-citation xml:lang="en">Phelps K.R., Oh M.S., Carroll H.J. Heparin-induced hyperkalemia. Report of a case Nephron 1980; 25: 254.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Sherman R.A., Ruddy M.C. Suppression of aldosterone production by low-dose heparin. Am J Nephrol 1986; 6: 165.</mixed-citation><mixed-citation xml:lang="en">Sherman R.A., Ruddy M.C. Suppression of aldosterone production by low-dose heparin. Am J Nephrol 1986; 6: 165.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">О’Kelly R., Magee F., McKenna T.F. Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocrinol Metab 1983; 56: 108-112.</mixed-citation><mixed-citation xml:lang="en">О’Kelly R., Magee F., McKenna T.F. Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocrinol Metab 1983; 56: 108-112.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Edes Т.Е., Sunderrajan E.V. Heparin-induced hyperkalemia. Arch Intern Med 1985; 145: 1070-1072.</mixed-citation><mixed-citation xml:lang="en">Edes Т.Е., Sunderrajan E.V. Heparin-induced hyperkalemia. Arch Intern Med 1985; 145: 1070-1072.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Oster J.R., Singer I., Fishman L.M. Heparin-induced aldosterone suppresion and hyperkalemia. Am J Med 1995; 98: 575-586.</mixed-citation><mixed-citation xml:lang="en">Oster J.R., Singer I., Fishman L.M. Heparin-induced aldosterone suppresion and hyperkalemia. Am J Med 1995; 98: 575-586.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Martin G., Diaz-Molinas M.S., Martinez A.M. et al. Heparin-induced hyperkalemia: a prospective study. Inl J Clin Pharmacol Ther Toxicol 1991; 29: 446-450.</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Martin G., Diaz-Molinas M.S., Martinez A.M. et al. Heparin-induced hyperkalemia: a prospective study. Inl J Clin Pharmacol Ther Toxicol 1991; 29: 446-450.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Durand D., Ader J.-L., Rey J.-P. et al. Inducing hyperkalemia by converting enzyme inhibitors and heparin. Kidney Int1988; 34 [Suppl25]: S196-S197.</mixed-citation><mixed-citation xml:lang="en">Durand D., Ader J.-L., Rey J.-P. et al. Inducing hyperkalemia by converting enzyme inhibitors and heparin. Kidney Int1988; 34 [Suppl25]: S196-S197.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Antonipillai I., Wang Y., Horton R. Tumor necrosis factor and inlerleukin-1 may regulate renin secretion. Endocrinology 1990; 126: 273-278.</mixed-citation><mixed-citation xml:lang="en">Antonipillai I., Wang Y., Horton R. Tumor necrosis factor and inlerleukin-1 may regulate renin secretion. Endocrinology 1990; 126: 273-278.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Canova C.R., Fischler M.P., Reinhart W.H. Effect of low-molecular-wcight heparin on serum potassium. Lancet 1997; 349: 1447-1448.</mixed-citation><mixed-citation xml:lang="en">Canova C.R., Fischler M.P., Reinhart W.H. Effect of low-molecular-wcight heparin on serum potassium. Lancet 1997; 349: 1447-1448.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Wiggam M.I., Beringer T.R.O. Effect of low-molccular-weight heparin on serum concentrations of potassium. Lancet 1997; 350: 292-293.</mixed-citation><mixed-citation xml:lang="en">Wiggam M.I., Beringer T.R.O. Effect of low-molccular-weight heparin on serum concentrations of potassium. Lancet 1997; 350: 292-293.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Kleyman T.R., Robers С., Ling B.N. A mechanism for pentamid-ine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med 1995; 122: 103-106.</mixed-citation><mixed-citation xml:lang="en">Kleyman T.R., Robers С., Ling B.N. A mechanism for pentamid-ine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med 1995; 122: 103-106.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Kalin M., Poretsky L., Seres D.J., Zumoff B. Hypereninemic hypoaldosteronism associated with AIDS. Am J Med 1987; 82: 1035-1038.</mixed-citation><mixed-citation xml:lang="en">Kalin M., Poretsky L., Seres D.J., Zumoff B. Hypereninemic hypoaldosteronism associated with AIDS. Am J Med 1987; 82: 1035-1038.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Kamel K.S., Ethier J.H., Quaggin S. et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 1991; 2: 1279-1284.</mixed-citation><mixed-citation xml:lang="en">Kamel K.S., Ethier J.H., Quaggin S. et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 1991; 2: 1279-1284.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Bantle J.P., Nath K.A., Sutherland E.R., Najarian J.S., Ferns T.F. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 1985; 145: 505-508.</mixed-citation><mixed-citation xml:lang="en">Bantle J.P., Nath K.A., Sutherland E.R., Najarian J.S., Ferns T.F. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 1985; 145: 505-508.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Smith T.W. Digitalis: Mechanisms of action and clinical use. N Engl J Med 1988; 318: 358-365.</mixed-citation><mixed-citation xml:lang="en">Smith T.W. Digitalis: Mechanisms of action and clinical use. N Engl J Med 1988; 318: 358-365.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Lown B., Black A., Moore F.D. Digitalis, electrolytes and the surgical patient. Am J Cardiol 1960; 6: 309-311.</mixed-citation><mixed-citation xml:lang="en">Lown B., Black A., Moore F.D. Digitalis, electrolytes and the surgical patient. Am J Cardiol 1960; 6: 309-311.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Asplund J., Edhag О., Mogensen L. et al. Four cases of massive digitalis poisoning. Acta Med Scand 1971; 189: 293-297.</mixed-citation><mixed-citation xml:lang="en">Asplund J., Edhag О., Mogensen L. et al. Four cases of massive digitalis poisoning. Acta Med Scand 1971; 189: 293-297.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Reza M.J., Kovick R.B., Shine K.I., Pearce M.L. Massive intravenous digoxin overdosage. N Engi J Med 1974; 291: 777-778.</mixed-citation><mixed-citation xml:lang="en">Reza M.J., Kovick R.B., Shine K.I., Pearce M.L. Massive intravenous digoxin overdosage. N Engi J Med 1974; 291: 777-778.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
